Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination.
about
Zika Virus: New Clinical Syndromes and Its Emergence in the Western HemisphereFlavivirus NS1 protein in infected host sera enhances viral acquisition by mosquitoesGenetic dissection of Flaviviridae host factors through genome-scale CRISPR screensAntibody-Dependent Enhancement of Dengue Virus Infection in Primary Human Macrophages; Balancing Higher Fusion against Antiviral ResponsesFlavivirus NS1: a multifaceted enigmatic viral proteinExtended surface for membrane association in Zika virus NS1 structureExtended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever PatientsDengue Fever: Causes, Complications, and Vaccine StrategiesDengue Virus NS1 Disrupts the Endothelial Glycocalyx, Leading to HyperpermeabilityDengue virus infection induces interferon-lambda1 to facilitate cell migrationDengue Virus Nonstructural Protein 1 Induces Vascular Leakage through Macrophage Migration Inhibitory Factor and AutophagyContribution of intertwined loop to membrane association revealed by Zika virus full‐length NS1 structureVitamin D-Regulated MicroRNAs: Are They Protective Factors against Dengue Virus Infection?Recent advances in understanding denguePathogenesis of Dengue: Dawn of a New EraCaveolae-mediated albumin transcytosis is enhanced in dengue-infected human endothelial cells: A model of vascular leakage in dengue hemorrhagic feverModeling Dengue Virus-Hepatic Cell Interactions Using Human Pluripotent Stem Cell-Derived Hepatocyte-like CellsNeutrophil Extracellular Traps Go ViralVaccines and immunization strategies for dengue preventionDengue: knowledge gaps, unmet needs, and research prioritiesThe Complement System in Flavivirus InfectionsCharacterization of Zika virus binding and enhancement potential of a large panel of flavivirus murine monoclonal antibodies.18F-FDG as an inflammation biomarker for imaging dengue virus infection and treatment responseDengue virus NS1 enhances viral replication and pro-inflammatory cytokine production in human dendritic cells.NS1: A corner piece in the dengue pathogenesis puzzle?Current Status of Dengue Therapeutics Research and Development.Hypoxia enhances antibody-dependent dengue virus infectionThe Role of Heterotypic DENV-specific CD8+T Lymphocytes in an Immunocompetent Mouse Model of Secondary Dengue Virus Infection.Immune correlates for dengue vaccine developmentDengue Virus Nonstructural Protein 1-Induced Antibodies Cross-React with Human Plasminogen and Enhance Its Activation.Pathogen-specific deep sequence-coupled biopanning: A method for surveying human antibody responses.Mathematical modelling and a systems science approach to describe the role of cytokines in the evolution of severe dengueSerum from dengue virus-infected patients with and without plasma leakage differentially affects endothelial cells barrier function in vitroPrimary dengue virus infections induce differential cytokine production in Mexican patients.Association of Microvascular Function and Endothelial Biomarkers With Clinical Outcome in Dengue: An Observational StudySecretory phospholipase A2 in the pathogenesis of acute dengue infection.Increased Serum Hyaluronic Acid and Heparan Sulfate in Dengue Fever: Association with Plasma Leakage and Disease Severity.Recent advances in understanding the adaptive immune response to Zika virus and the effect of previous flavivirus exposure.Zika Virus as an Emerging Neuropathogen: Mechanisms of Neurovirulence and Neuro-Immune Interactions.T cell immunity to dengue virus and implications for vaccine design.
P2860
Q24261248-D28466A7-EF71-49DB-BF68-889029027830Q24705181-58EEDBB5-EDD4-4A8E-A230-845E2897E988Q24705236-DD74E56C-4771-4D34-91A8-91CC5458C9D9Q25708015-7902BD6D-EE9F-4966-A81E-5C3FC379FC5FQ26247192-C15736A8-E4EB-4831-9EC8-03713F93EA16Q26252232-A5C229CB-AC5F-4891-A524-55BC1D0741E9Q26257542-6E16E534-B20E-41A4-B553-E3F00BE474CDQ26700082-9BE62FA3-2A11-4F78-B69E-D75CBE3BAD6CQ26700100-5F51D1A2-5115-455A-971A-ED6A21135032Q26700107-6C6D533A-E4B8-4EB7-ACC4-6E4D5DDA3135Q26700117-22673CBA-DBC4-48AC-8DD0-029EE537CFE3Q26742214-0F50793C-F0BF-4141-9FA6-E1B6ACB6B36BQ26746990-3AA12598-6476-444C-83A3-1095DB20B156Q26766156-3D753FC7-A682-4E7B-9D29-195720A94449Q26766198-4470AD71-61E4-4558-9E34-54BBFE2B1D5FQ27468860-EAB8822E-FF44-46AB-A042-833A1312AB59Q27468864-B71AA9DB-C30F-4626-9A68-23343CD0C53DQ28075970-8AFB5E3D-EC55-4FB2-A366-E9231C153EA9Q28077521-C91B4705-A427-4227-A74D-02649B94E8E7Q28729764-3D67A01D-55F6-4A32-95D7-F284868BEF23Q28954726-62BFCA11-C7B0-4944-8E86-F8C6BF404353Q30145645-D99A2ADB-4367-43F6-AF23-E9C2E9F6AE60Q30250993-A118DD08-F914-409A-B397-60A51EF9513FQ31110897-81A7A2A8-D2D6-4DD8-8682-E23D25DFF3E9Q33361468-C3B4DD58-7BF7-44F5-AF2A-7CDEE322F34CQ33552896-044DA6D3-FD8E-42E6-B328-85503D265BF0Q33679954-69A0AF7A-E863-4C0A-8556-09A46453C3DEQ33817714-03F9710B-4541-431E-99F3-FAFDDAD714D5Q33924674-C0EFABC5-9BF5-4A25-BDBD-C7FCF476265FQ35880303-6444854B-FE44-4DED-8756-F90C19436312Q36267886-C8B6C430-AF58-4506-B1E8-D47CF31552C2Q36305184-F0CF72BC-91C2-4C59-A7DD-F05862B1F4C2Q36394066-618579E8-6719-44F1-A012-636C472B7642Q36720238-768F7EFE-57E7-4A69-84FE-30C9BD8174ADQ37161920-59743191-0A2C-4B6C-8EB7-908C6AC25DD7Q37660743-1F17FC3F-7BCE-49A0-BB50-106AE8332CFBQ37743291-A63B06E9-AA41-46A5-97D3-EACA61A81969Q38158407-FA391679-F543-44DD-BF1C-23CADBCEE782Q38158918-F4DC79B6-9056-4F0B-91A8-EB9B3BA80E0AQ38631171-CA1D00E7-E812-46E3-8FA8-89A057D6B11B
P2860
Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Dengue virus NS1 triggers endo ...... prevented by NS1 vaccination.
@en
type
label
Dengue virus NS1 triggers endo ...... prevented by NS1 vaccination.
@en
prefLabel
Dengue virus NS1 triggers endo ...... prevented by NS1 vaccination.
@en
P2093
P2860
P1476
Dengue virus NS1 triggers endo ...... prevented by NS1 vaccination.
@en
P2093
Henry Puerta-Guardo
Kaycie Hopkins
P Robert Beatty
Sarah S Killingbeck
P2860
P304
P356
10.1126/SCITRANSLMED.AAA3787
P407
P577
2015-09-01T00:00:00Z